S
Sirrus Pharmaceuticals Private Ltd.
A wide variety of services, including API & FDF development and manufacturing. Our Clients.
Country/Area ：India
Company address ：153, VENUS APARTMENTSECTOR-9, ROHINI, DELHI DELHI
Company website ：*****
Company phone ：+91 9152125656,+ 91 22 66921445
Established ：2008
Business Info
CIN ：U24232DL2008PTC184762
Registered State ：Delhi
Registrar Of Companies ：RoC-Delhi
Category ：Company limited by Shares
Sub Category ：Non-govt company
Company Class ：Private
Company Status ：Active
Registered Office Address ：153,Venus Appartment, Sector-9,Rohini NEW DELHI DL IN 110085
Authorized Cap ：100000.00
Paidup Capital ：100000.00
Web Summary
Q1: What is the physical address of Sirius Pharmaceuticals Pvt. Ltd.?
A1: The physical address of Sirius Pharmaceuticals Pvt. Ltd. is 301, Sai Nara 21, North Ave. & Linking Rd. Jn., Santacruz (w), Mumbai 400054, India.
Q2: How long has Sirius Pharmaceuticals Pvt. Ltd. been in operation?
A2: Sirius Pharmaceuticals Pvt. Ltd. was incorporated in 1990 and has been servicing international US FDA approved API facilities since 1996.
Q3: What is the focus of Sirius Pharmaceuticals Pvt. Ltd. in terms of product development?
A3: The focus of Sirius Pharmaceuticals Pvt. Ltd. is on providing inputs in terms of product specifications, Route of Synthesis, Method of Analysis, which enables a speedup of the product development process and secures a competitive price for customers.
Q4: What are the criteria that Sirius Pharmaceuticals Pvt. Ltd. uses to select its suppliers?
A4: The criteria used by Sirius Pharmaceuticals Pvt. Ltd. to select its suppliers include timely supplies, the optimum balance between quality and price, and adherence to SHE (Safety, Health, and Environment) standards.
Q5: How does Sirius Pharmaceuticals Pvt. Ltd. ensure compliance with regulatory requirements for its customers?
A5: Sirius Pharmaceuticals Pvt. Ltd. ensures compliance with regulatory requirements through regular audits of manufacturers' facilities, systems, and documentation, as well as constant followups and updates to ensure timely and relevant compliance with customers and regulatory requirements.
Q6: What types of products does Sirius Pharmaceuticals Pvt. Ltd. offer for scaleup?
A6: Sirius Pharmaceuticals Pvt. Ltd. offers a range of products for scaleup, including intermediates, APIs (Active Pharmaceutical Ingredients), Finished Dosage Forms, API Impurities, and Products available for Scale up.
Q7: Can you provide more information on the specific products offered by Sirius Pharmaceuticals Pvt. Ltd., such as Abacavir and Apixaban?
A7: Yes, some of the specific products offered by Sirius Pharmaceuticals Pvt. Ltd. include Abacavir (4(2Chloroethyl) Morpholine HCl), Apixaban (5,6Dihydro3(4Morpholinyl)1(4Nitrophenyl)2(1H)Pyridinone and 5,6Dihydro3(4Morpholinyl)1(4[2Oxo1Piperdinyl]Phenyl)2(1H)Pyridinone), Aprepitant/Fosaprepitant (2R,3S)2[(1R)1[3,5Bis(trifluoromethyl)phenyl]ethoxy]3(4fluorophenyl)morpholine hydrochloride, and others.
Q8: What is the company's experience in contract manufacturing of critical pharmaceutical intermediates?
A8: Sirius Pharmaceuticals Pvt. Ltd. has over 34 years of experience in contract manufacturing of critical pharmaceutical intermediates.
A1: The physical address of Sirius Pharmaceuticals Pvt. Ltd. is 301, Sai Nara 21, North Ave. & Linking Rd. Jn., Santacruz (w), Mumbai 400054, India.
Q2: How long has Sirius Pharmaceuticals Pvt. Ltd. been in operation?
A2: Sirius Pharmaceuticals Pvt. Ltd. was incorporated in 1990 and has been servicing international US FDA approved API facilities since 1996.
Q3: What is the focus of Sirius Pharmaceuticals Pvt. Ltd. in terms of product development?
A3: The focus of Sirius Pharmaceuticals Pvt. Ltd. is on providing inputs in terms of product specifications, Route of Synthesis, Method of Analysis, which enables a speedup of the product development process and secures a competitive price for customers.
Q4: What are the criteria that Sirius Pharmaceuticals Pvt. Ltd. uses to select its suppliers?
A4: The criteria used by Sirius Pharmaceuticals Pvt. Ltd. to select its suppliers include timely supplies, the optimum balance between quality and price, and adherence to SHE (Safety, Health, and Environment) standards.
Q5: How does Sirius Pharmaceuticals Pvt. Ltd. ensure compliance with regulatory requirements for its customers?
A5: Sirius Pharmaceuticals Pvt. Ltd. ensures compliance with regulatory requirements through regular audits of manufacturers' facilities, systems, and documentation, as well as constant followups and updates to ensure timely and relevant compliance with customers and regulatory requirements.
Q6: What types of products does Sirius Pharmaceuticals Pvt. Ltd. offer for scaleup?
A6: Sirius Pharmaceuticals Pvt. Ltd. offers a range of products for scaleup, including intermediates, APIs (Active Pharmaceutical Ingredients), Finished Dosage Forms, API Impurities, and Products available for Scale up.
Q7: Can you provide more information on the specific products offered by Sirius Pharmaceuticals Pvt. Ltd., such as Abacavir and Apixaban?
A7: Yes, some of the specific products offered by Sirius Pharmaceuticals Pvt. Ltd. include Abacavir (4(2Chloroethyl) Morpholine HCl), Apixaban (5,6Dihydro3(4Morpholinyl)1(4Nitrophenyl)2(1H)Pyridinone and 5,6Dihydro3(4Morpholinyl)1(4[2Oxo1Piperdinyl]Phenyl)2(1H)Pyridinone), Aprepitant/Fosaprepitant (2R,3S)2[(1R)1[3,5Bis(trifluoromethyl)phenyl]ethoxy]3(4fluorophenyl)morpholine hydrochloride, and others.
Q8: What is the company's experience in contract manufacturing of critical pharmaceutical intermediates?
A8: Sirius Pharmaceuticals Pvt. Ltd. has over 34 years of experience in contract manufacturing of critical pharmaceutical intermediates.
Customs Data
As a purchaser
As a Supplier
Get the Whole details
Contact
Total found ??? Contacts
All
Boss
Management
Procurement
Other
Get the Whole details
